The Genetics Podcast
The Genetics Podcast
Sano Genetics
EP 233: Unlocking early detection in liver disease with data and genetics with Tim Jobson of Predictive Health Intelligence
33 minutes Posted Apr 2, 2026 at 11:00 am.
Intro to The Genetics Podcast00:59 Welcome to Tim01:50 The rise of metabolic liver disease and worsening mortality trends04:35 Motivation and goals behind the Somerset Liver Improvement Program to address late diagnosis09:13 Where genetics is already used in liver disease and where it’s still emerging13:17 Current tools for staging liver disease and the challenge of predicting progression at scale18:48 How the LiveWell study could improve risk prediction and reshape trial recruitment in liver disease23:58 Applying longitudinal risk detection beyond liver disease to cardiometabolic and other chronic conditions26:35 Using subtle changes in routine blood tests to identify cancer risk earlier28:09 Using existing health data to drive earlier intervention and maximize patient impact30:05 Expanding beyond liver disease, scaling early detection, and advancing precision medicine32:18 Closing remarksPlease consider rating and reviewing us on your chosen podcast listening platform!
0:00
33:23
Download MP3
Show notes
This week on The Genetics Podcast, Patrick is joined by Dr. Tim Jobson, consultant physician and gastroenterologist at Somerset NHS Foundation Trust and Medical Director of Predictive Health Intelligence (PHI). They discuss the rising burden of metabolic liver disease and how routine clinical data can be used to detect disease earlier and prevent late-stage presentation. They also discuss the LiveWell study, a collaboration between Sano Genetics and PHI, and what it reveals about layering genetics and other data types to improve risk stratification and clinical trial recruitment. Show Notes0:00 Intro to The Genetics Podcast00:59 Welcome to Tim01:50 The rise of metabolic liver disease and worsening mortality trends04:35 Motivation and goals behind the Somerset Liver Improvement Program to address late diagnosis09:13 Where genetics is already used in liver disease and where it’s still emerging13:17 Current tools for staging liver disease and the challenge of predicting progression at scale18:48 How the LiveWell study could improve risk prediction and reshape trial recruitment in liver disease23:58 Applying longitudinal risk detection beyond liver disease to cardiometabolic and other chronic conditions26:35 Using subtle changes in routine blood tests to identify cancer risk earlier28:09 Using existing health data to drive earlier intervention and maximize patient impact30:05 Expanding beyond liver disease, scaling early detection, and advancing precision medicine32:18 Closing remarksPlease consider rating and reviewing us on your chosen podcast listening platform!